Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Acta Poloniae Pharmaceutica|January 1, 1992
[Study of the synthesis of pyrazine derivates. Part XXVIII. Reaction of pyrazineamide with CS-2]H Foks, C Orlewska, M JanowiecJournal of Microbiological Methods|October 14, 2014
Comparison of fluorescence optical respirometry and microbroth dilution methods for testing antimicrobial compoundsR Hałasa, K Turecka, C Orlewska, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|May 4, 2010
Blockade of calcium channels and AT1 receptor prevents the hypertensive effect of calcilytic NPS 2143 in ratsA Rybczynska, A Jurska-Jasko, K Boblewski, et al.Molecular and Cellular Biochemistry|February 12, 2011
Metabolism of 4-pyridone-3-carboxamide-1-β-D-ribonucleoside (4PYR) in rodent tissues and in vivoP Romaszko, E M Slominska, C Orlewska, et al.Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Protection of mouse heart against hypoxic damage by AMP deaminase inhibitionT Borkowski, E M Slominska, C Orlewska, et al.Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Biological efficiency of AMP deaminase inhibitor: 3-[2-(3-carboxy-4-bromo-5,6,7,8-tetrahydronaphthyl)ethyl]-3,6,7,8-tetrahydroimidazo[4,5]-[1,3]diazepin-8-OLT Borkowski, E M Slominska, C Orlewska, et al.Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Pharmacological inhibition of AMP-deaminase in rat cardiac myocytesT Borkowski, C Orlewska, E M Slominska, et al.Nucleosides, Nucleotides & Nucleic Acids|July 5, 2008
Metabolism of 4-pyridone-3-carboxamide-1-beta-D-ribonucleoside triphosphate and its nucleoside precursor in the erythrocytesE M Slominska, C Orlewska, A Yuen, et al.RSC Advances|November 13, 2024
Physicochemical properties and mechanism of action of a new copper(ii) pyrazine-based complex with high anticancer activity and selectivity towards cancer cellsB Rogalewicz, T Sierański, M Szczesio, et al.Pageof 1